• 020 3869 8790

Rationale and design of the intravenous iron for treatment of anemia before cardiac surgery trial

Professor Toby Richards, our Clinical Lead for Vascular Surgery, and his colleagues are testing the benefits and risks of IV iron administration in anemic patients awaiting cardiac surgery. This is important research, given that 20-30% of patients awaiting cardiac surgery are anemic, and that this increases the likelihood of requiring a red cell transfusion and is associated with further complications, intensive care, and hospital stay following surgery.

Iron deficiency is the primary cause of anemia and so administering it preoperatively may tackle the disease, and improve patient outcomes following cardiac surgery.

Read the full report here

Other news

30th August 2022

Management of haematoma after thyroid surgery

Our Lead Anaesthetist, Imran Ahmad, has published a recent paper which includes a systematic review to inform recommendations on…
30th June 2022

Gastroenterology Today – Summer Edition

In the latest edition of Gastroenterology Today, Dr Matthew Banks, Clinical Lead 18 Week Support Gastroenterology, explores what it is…
28th May 2022

Retinal Detachment

UK Biobank project that our Ophthalmology Clinical Lead, Danny Mitry is involved with, focuses on Rhegmatogenous retinal detachment (RRD),…